The estimated Net Worth of Mostafa Kamal is at least $13.3 Milhão dollars as of 3 March 2021. Mr. Kamal owns over 6,242 units of Magellan Health Inc stock worth over $861,179 and over the last 9 years he sold MGLN stock worth over $9,481,283. In addition, he makes $2,911,750 as Chief Executive Officer - Magellan Rx Management at Magellan Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Kamal MGLN stock SEC Form 4 insiders trading
Mostafa has made over 24 trades of the Magellan Health Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 6,242 units of MGLN stock worth $592,928 on 3 March 2021.
The largest trade he's ever made was selling 20,885 units of Magellan Health Inc stock on 13 November 2020 worth over $1,771,466. On average, Mostafa trades about 4,083 units every 47 days since 2015. As of 3 March 2021 he still owns at least 9,066 units of Magellan Health Inc stock.
You can see the complete history of Mr. Kamal stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mostafa Kamal biography
Mostafa M. Kamal serves as Chief Executive Officer - Magellan Rx Management of the Company. Mr. Kamal previously served as senior vice president and general manager of Magellan Rx Management’s specialty pharmacy business, as well as its chief underwriting officer. From 2011 to 2014, Mr. Kamal was vice president of pricing, underwriting and analytics. Before joining the company, he served as director of strategy and analytics at Medco Health Solutions, Inc. (now known as Express Scripts). He currently serves as a director of the Pharmaceutical Care Management Association.
What is the salary of Mostafa Kamal?
As the Chief Executive Officer - Magellan Rx Management of Magellan Health Inc, the total compensation of Mostafa Kamal at Magellan Health Inc is $2,911,750. There are 1 executives at Magellan Health Inc getting paid more, with Kenneth Fasola having the highest compensation of $4,880,750.
How old is Mostafa Kamal?
Mostafa Kamal is 39, he's been the Chief Executive Officer - Magellan Rx Management of Magellan Health Inc since 2015. There are 14 older and no younger executives at Magellan Health Inc. The oldest executive at Magellan Health Inc is Mural Josephson, 70, who is the Director.
What's Mostafa Kamal's mailing address?
Mostafa's mailing address filed with the SEC is 15950 N 76th St #200, Scottsdale, AZ 85260, USA.
Insiders trading at Magellan Health Inc
Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray, eMary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.
What does Magellan Health Inc do?
Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.
What does Magellan Health Inc's logo look like?
Complete history of Mr. Kamal stock trades at Magellan Health Inc
Magellan Health Inc executives and stock owners
Magellan Health Inc executives and other stock owners filed with the SEC include:
-
Kenneth Fasola,
Chief Executive Officer, Director -
Mostafa Kamal,
Chief Executive Officer - Magellan Rx Management -
Steven Shulman,
Independent Chairman of the Board -
Caskie Lewis-Clapper,
Chief Human Resource Officer -
Peter Feld,
Independent Director -
G. Scott MacKenzie,
Independent Director -
Guy Sansone,
Independent Director -
Leslie Norwalk,
Independent Director -
Swati Abbott,
Independent Director -
Joe Bogdan,
Senior Vice President, Corporate Finance -
Mural Josephson,
Director -
Christopher Chen,
Director -
Tim Lacy,
Chief Growth Officer -
Caroline Carney,
Chief Medical Officer -
David Haddock,
General Counsel, Secretary -
David Bourdon,
Chief Financial Officer -
James Murray,
President, Chief Operating Officer -
Jay Youell,
Sr. VP of Sales - Health Plan & Insurance Markets -
John E. Littel,
Chief External Affairs Officer -
Darren P. Lehrich,
Chief Investor Relations Officer -
Renie Shapiro Silver,
SVP - Corp. Fin. -
David Patrick Bourdon,
Chief Financial Officer -
William J Mcbride,
Director -
Eran Broshy,
Director -
Barry M Smith,
Director -
Perry G Md Fine,
Director -
Kay Coles James,
Director -
John O Agwunobi,
Director -
Jeffrey N West,
SVP & Controller -
Sanjeev K Srivastava,
CEO, Magellan Plan Services -
Mary F Sammons,
Director -
Jonathan N Rubin,
Chief Financial Officer -
Michael Diament,
Director -
Daniel N Gregoire,
General Counsel and Secretary -
Russell C Petrella,
President, Behavioral Health -
Mark S Demilio,
CFO -
Raju L Mantena,
President, ICORE Healthcare -
Robert W Field,
CEO, Magellan Pharm Solutions -
Michael P Ressner,
Director -
Tina Blasi,
CEO, National Imaging Assoc. -
Robert M Leblanc,
Director -
Management, L.P.Cohen Arthu...,
-
Kim Marie Mageau,
President, Magellan Pharm Sols -
Alan Lotvin,
President, ICore Healthcare -
Management, L.P.Health Cor ...,
-
Timothy P Nolan,
President, First Health Servic -
Karen S Lynch,
President -
Nancy L Johnson,
Director -
Allen F Wise,
Director -
Jeff D Emerson,
Chief Information Officer -
Rene Lerer,
President and COO -
Eric Reimer,
Chief Growth Officer -
William D Forrest,
Director -
Anthony M Kotin,
Chief Mkting & Strategy Offcr -
Saul Burian,
Director -
Keith Dixon,
President, Behavioral Health -
Holdings Lp Onex Partners G...,
-
Michael Majerik,
Chief Sales&Marketing Officer -
Matthew Joseph Simas,
Director -
Robert M Haft,
Director -
Gadget, L.P.Scepter Holding...,
-
Megan M Arthur,
Executive Vice President -
Holdings Lponex Partners Lp...,